Stock AMIX AUTONOMIX MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Autonomix Medical, Inc.

Equities

AMIX

US05330T1060

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
2.28 USD +7.55% Intraday chart for Autonomix Medical, Inc. -2.36% -.--%
Apr. 25 Autonomix Enters into Agreement with Noisefigure Research, Inc. to Develop Next Generation of Its Proprietary Microchip CI
Apr. 16 Autonomix Medical Secures US Patent for Catheter-Based Technology to Treat Cancer-Related Pain MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update
AQ
Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer
AQ
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series
AQ
Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip
AQ
Autonomix Enters into Agreement with Noisefigure Research, Inc. to Develop Next Generation of Its Proprietary Microchip
CI
Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
AQ
Autonomix Medical Inc Covered in Benzinga Article Highlighting Innovative Nerve Treatment Tech
AQ
Autonomix Medical Secures US Patent for Catheter-Based Technology to Treat Cancer-Related Pain
MT
Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain
AQ
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
AQ
Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation
AQ
Autonomix Medical, Inc. Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation
CI
Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker
AQ
Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference
AQ
 Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024
AQ
Autonomix Appoints Jennifer Cook as Chief Business Officer
AQ
Autonomix Appoints Jennifer Cook as Chief Business Officer
CI
Autonomix Medical, Inc.(NasdaqCM:AMIX) added to S&P TMI Index
CI
Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
AQ
Autonomix Medical, Inc. Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AMIX Stock
  4. News Autonomix Medical, Inc.